Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tadaharu Tsuchiya
Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy
Journal of Ophthalmology
Ophthalmology
Related publications
Efficacy and Safety of Switching From Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy
Open Ophthalmology Journal
Ophthalmology
Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy
Clinical Ophthalmology
Ophthalmology
Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost
Open Ophthalmology Journal
Ophthalmology
Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension
Clinical Ophthalmology
Ophthalmology
Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2α Analog
Clinical Ophthalmology
Ophthalmology
Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Advances in Therapy
Medicine
Pharmacology
Additive Intraocular Pressure-Lowering Effect of Dorzolamide 1%/Timolol 0.5% Fixed Combination on Prostaglandin Monotherapy in Patients With Normal Tension Glaucoma
Clinical Ophthalmology
Ophthalmology
24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy
Advances in Therapy
Medicine
Pharmacology
Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation
Clinical Ophthalmology
Ophthalmology